NovaBay Pharma (NBY) Tops Q4 EPS by 10c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q4 EPS of ($1.26), $0.10 better than the analyst estimate of ($1.36). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.16 million.
Cash, cash equivalents and short-term investments were $2.4 million as of December 31, 2015, compared with $5.4 million as of December 31, 2014.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
